You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 7, July 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cystic Fibrosis Survival Rates

The Influences of Allergy and Pseudomonas aeruginosa

Robert W. Wilmott, MD, MRCP(UK); Saba L. Tyson; Duncan J. Matthew, FRCP(UK)

Am J Dis Child. 1985;139(7):669-671.


Abstract

• Allergy and chronic Pseudomonas aeruginosa (PA) infection are two factors that possibly affect the clinical severity of cystic fibrosis pulmonary disease, although the role of allergy is controversial. We have examined the effects of these factors on actuarial survival rates in 117 children with cystic fibrosis who were skin tested in 1974 and classified as allergic (A+) or nonallergic (A–) by their reactions to 12 prick tests with common environmental allergens. Patients were also classified according to whether or not they had chronic pulmonary infection with PA in 1974 (PA-positive or PA-negative). Survival rates in A + patients were not significantly different from those in the A– group (percent survival to age 16 years, 67% vs 80%), whereas the PA+ group had significantly worse survival rates than the PA– group (percent survival to age 16 years, 53% vs 84%). There was no significant interaction between allergic skin reactions and either age at onset of chronic PA Infection or subsequent duration of survival.

(AJDC 1985;139:669-671)



Author Affiliations

From the Respiratory Unit, The Hospital for Sick Children, London. Dr Wilmott is now with The Children's Hospital of Philadelphia.


Footnotes

Reprint requests to the Pulmonology Section, Division of Allergy, Immunology, and Pulmonology, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104 (Dr Wilmott).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lung Function from Infancy to the Preschool Years after Clinical Diagnosis of Cystic Fibrosis
Kozlowska et al.
Am. J. Respir. Crit. Care Med. 2008;178:42-49.
ABSTRACT | FULL TEXT  

Segregation is good for patients with cystic fibrosis
Conway
JRSM 2008;101:31-35.
FULL TEXT  

Advancing Outcome Measures for the New Era of Drug Development in Cystic Fibrosis
Mayer-Hamblett et al.
Proc Am Thorac Soc 2007;4:370-377.
ABSTRACT | FULL TEXT  

Profile and factors determining outcome in a cohort of cystic fibrosis patients seen at the aga khan university hospital, karachi, pakistan.
Shah et al.
J Trop Pediatr 2006;52:132-135.
ABSTRACT | FULL TEXT  

Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis
Farrell et al.
Am. J. Respir. Crit. Care Med. 2003;168:1100-1108.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.